Pharma
Despite FDA crackdown, unapproved GLP-1s still threaten the industry
Legitimate compounders are threatened by false advertising of counterfeit GLP-1s, legal experts warn.
Pharma
Pharma
Could relaxed regulations boost gene therapy for ultra-rare diseases?
Companies like Prime Medicine and Aurora Therapeutics are shooting their shot.
Pharma
Supply chain leaders were excited by Supreme Court tariff strikedown, though still very confused
Tariffs have brought a “wave of chaos and confusion to the global supply chains,” one expert says.
Pharma
FDA Commissioner Marty Makary talks the ‘AI revolution’ at the agency
Makary shared his thoughts on AI’s future potential in an interview with Healthcare Brew.
Pharma
GoodRx, Eli Lilly launch direct-to-employer models that reduce reliance on PBMs
Is direct to employer the new direct to consumer?
Pharma
North Carolina’s Research Triangle sees big investments despite NIH cuts
Johnson & Johnson, Amgen, and Fujifilm Biotechnologies have all recently invested in the RTP.
Pharma
Immuneering CEO shares his cancer drug development strategy
“Slow and steady” beats “flashy” when it comes to treating cancer, CEO Ben Zeskind says.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
